News

Remap Consulting receives award at LTEN excellence awards in Dallas

It was great to receive our LTEN Excellence Finalist Award in Dallas on Monday in partnership with Amgen for training we delivered earlier this year. Contact us () to find out how we can help you with your market access training needs.

By |2019-06-18T14:45:34+01:00June 16th, 2019|News|0 Comments

Industry partner finalists for our bespoke pricing and market access training programme

Fingers crossed for Remap Consulting at the @LTEN launch excellence awards who have been nominated as finalists within the Providers of Industry Partnership category for the creation of a bespoke pricing and market access training programme in 12 countries in partnership with #Amgen

Finalists

The LTEN Excellence Awards is an annual competition that celebrates the people, companies and industry partners demonstrating ahead-of-the-curve thinking in training and development initiatives, learning technology, content development, and delivery, and leadership within the life sciences.

By |2019-06-03T09:58:26+01:00June 6th, 2019|News|0 Comments

Graham attending the market access and pricing and reimbursement meeting at EUCOPE

Graham Foxon will be attending the market access and pricing and reimbursement meeting at EUCOPE today.

If you are attending, please feel free to reach out to Graham who will be happy to discuss any pricing and market access challenges that you may be facing.

EUCOPE meeting

By |2019-06-03T09:25:07+01:00June 4th, 2019|News|0 Comments

Paul attending the LTEN excellence awards in Dallas

Remap Consulting received a nomination within the Providers Industry Partnership category for our creation of bespoke pricing and market access training programme in partnership with Amgen and have been selected as finalists at the LTEN excellence awards.

Please join us in wishing Remap Consulting the best of luck!

By |2019-06-03T10:00:40+01:00June 3rd, 2019|News|0 Comments

What are precision medicines and are payers allowing market access?

What is the future of precision medicine in the EU?

The field of precision medicine is a complex area with many overlapping definitions and terminologies. Precision medicine is an umbrella term for the treatment and prevention of disease using a combination of drug and diagnostic, considering individual variability in genes, environment, and lifestyle. Manufacturers have found market access to be a significant challenge as countries adapt their existing pricing and reimbursement processes to account for the dual assessment of the drug and accompanying diagnostic. This article will explore the various definitions surrounding precision medicine, and the specific market access considerations for this growing area of research.

Why are payers interested in precision medicine?

Medicine that is truly unique to the patient, allowing for the best possible efficacy with minimal side effects, is often seen as the future of healthcare. The mainstream use of ‘personalised medicine’, where medical treatment is tailored to the individual […]

By |2019-06-27T14:21:48+01:00May 29th, 2019|News|0 Comments

NICE scientific advice: what happens after the UK leave the EU?

NICE have published guidance on what happens if they cannot be part of the parallel advice with the European Medicines Agency (EMA) via EUnetHTA?

  • All existing contracts will be honoured by producing their own advice letter and holding a NICE-specific face-to-face advisory meeting
  • They can provide a service where advice is sought from NICE concurrently with advice being sought from the EMA and other health technology assessment (HTA) bodies. The process in this eventuality is explained in their full article here
  • In addition to advice on clinical trial programmes, NICE can also hold in-depth discussions on modelling questions and provide access to world-class health economic experts
NICE will continue to offer joint advice with the Medicines and Healthcare products Regulatory Agency (MHRA)
By |2019-05-29T13:37:44+01:00May 28th, 2019|News|0 Comments

The LTEN Excellence Awards are almost here

Paul will be in Dallas on 3rd-6th June attending the LTEN Excellence Awards of which Remap Consulting have a nomination within the ‘Providers Industry Partnership’ category.

We are finalists in the Providers Industry Partnership category for the creation of bespoke pricing and market access training programmes in partnership with Amgen

The LTEN Excellence Awards honour life sciences training professionals in several categories, as well as designating LTEN Members of the Year.

 

By |2019-05-24T10:40:19+01:00May 27th, 2019|News|0 Comments

Analyst Vacancy at Remap Consulting

Are you looking for an exciting opportunity within a vibrant Company?

Remap Consulting has an excellent working environment with a fantastic work/life balance and a great rewards package to the right candidate.

Click on this link to find out more.

Apply now: careers@remapconsulting.com

Job vacancy

By |2019-05-24T10:33:11+01:00May 24th, 2019|Careers, News|0 Comments

Paul Craddy completes Cape Wrath Marathon

Paul had a fantastic time on Saturday at the Cape Wrath Marathon and managed to beat his own personal best with a time of 3hrs 57 mins. The scenery was stunning as you can see, the people were incredibly friendly and the race was very well organised.

Well done Paul for not only beating your personal best time but also raising a great amount of much-needed cash for our chosen charity, the East Cheshire Hospice.

cape wrath challenge

By |2019-06-20T14:21:15+01:00May 20th, 2019|News|0 Comments